Compare Continence Control Systems International vs Leptos BioMedical
Customers evaluate the quality of Continence Control Systems International's products using the following success metrics.
Overview
CCS is developing a device to aid colostomy patients in managing their stomas (formerly Uniseed investee Colocare) and a surgical procedure for urinary incontinence based on electrical stimulation of smooth muscle grafts. Both technologies are currently under clinical evaluation.
Leptos BioMedical is 22 yrs old and is based in United States.
Leptos Biomedical is developing an impressive new electrical stimulation device treating obesity.
Demo Video
Leadership
Hans Neisz (Chief Executive Officer)
Funding
Investors
Thomas McNerney & Partners, Technology Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Continence Control Systems International has not claimed their profile.
Work for Continence Control Systems International? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Continence Control Systems International?
Claim your profile now.
Information not available because Leptos BioMedical has not claimed their profile.
Work for Leptos BioMedical? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Leptos BioMedical?
Claim your profile now.